LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | QL-XII-47 | 1.11 | uM | LJP6 | 2 | O21 | 72 | hr | 1401 | 1607 | 4223 | 0.3805 | 0.0728 |
| SK-BR-3 | QL-XII-47 | 1.11 | uM | LJP6 | 3 | O21 | 72 | hr | 1401 | 1393 | 4223 | 0.3299 | -0.0030 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP5 | 1 | K09 | 72 | hr | 1401 | 2317 | 4223 | 0.5487 | 0.3245 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP5 | 2 | K09 | 72 | hr | 1401 | 1295 | 4223 | 0.3067 | -0.0378 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP5 | 3 | K09 | 72 | hr | 1401 | 1345 | 4223 | 0.3185 | -0.0200 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP6 | 1 | K09 | 72 | hr | 1401 | 1534 | 4223 | 0.3632 | 0.0470 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP6 | 2 | K09 | 72 | hr | 1401 | 1468 | 4223 | 0.3476 | 0.0236 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP6 | 3 | K09 | 72 | hr | 1401 | 1495 | 4223 | 0.3540 | 0.0331 |
| SK-BR-3 | Seliciclib | 1.11 | uM | LJP5 | 1 | J03 | 72 | hr | 1401 | 3597 | 4223 | 0.8518 | 0.7781 |
| SK-BR-3 | Seliciclib | 1.11 | uM | LJP5 | 2 | J03 | 72 | hr | 1401 | 3624 | 4223 | 0.8581 | 0.7877 |
| SK-BR-3 | Seliciclib | 1.11 | uM | LJP5 | 3 | J03 | 72 | hr | 1401 | 4068 | 4223 | 0.9633 | 0.9450 |
| SK-BR-3 | Ruxolitinib | 1.11 | uM | LJP5 | 1 | O15 | 72 | hr | 1401 | 3901 | 4223 | 0.9237 | 0.8859 |
| SK-BR-3 | Ruxolitinib | 1.11 | uM | LJP5 | 2 | O15 | 72 | hr | 1401 | 4257 | 4223 | 1.0080 | 1.0120 |
| SK-BR-3 | Ruxolitinib | 1.11 | uM | LJP5 | 3 | O15 | 72 | hr | 1401 | 4189 | 4223 | 0.9919 | 0.9879 |
| SK-BR-3 | XL147 | 1.11 | uM | LJP5 | 1 | G09 | 72 | hr | 1401 | 4963 | 4223 | 1.1752 | 1.2622 |
| SK-BR-3 | XL147 | 1.11 | uM | LJP5 | 2 | G09 | 72 | hr | 1401 | 5030 | 4223 | 1.1911 | 1.2860 |
| SK-BR-3 | XL147 | 1.11 | uM | LJP5 | 3 | G09 | 72 | hr | 1401 | 4839 | 4223 | 1.1458 | 1.2183 |
| SK-BR-3 | Saracatinib | 1.11 | uM | LJP6 | 1 | D09 | 72 | hr | 1401 | 4059 | 4223 | 0.9611 | 0.9418 |
| SK-BR-3 | Saracatinib | 1.11 | uM | LJP6 | 2 | D09 | 72 | hr | 1401 | 4147 | 4223 | 0.9820 | 0.9730 |
| SK-BR-3 | Saracatinib | 1.11 | uM | LJP6 | 3 | D09 | 72 | hr | 1401 | 4338 | 4223 | 1.0272 | 1.0407 |
| SK-BR-3 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 1401 | 4023 | 4223 | 0.9526 | 0.9291 |
| SK-BR-3 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 1401 | 3897 | 4223 | 0.9228 | 0.8844 |
| SK-BR-3 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 1401 | 4222 | 4223 | 0.9997 | 0.9996 |
| SK-BR-3 | Sirolimus | 1.11 | uM | LJP6 | 1 | L15 | 72 | hr | 1401 | 2530 | 4223 | 0.5991 | 0.4000 |
| SK-BR-3 | Sirolimus | 1.11 | uM | LJP6 | 2 | L15 | 72 | hr | 1401 | 2647 | 4223 | 0.6268 | 0.4414 |